Please enable JavaScript to continue using this application.

Compare $CYDY vs $RCKT | Chartloom

Compare

$CYDY vs $RCKT

Cytodyn Inc · Rocket Pharmaceuticals Inc

CYDY

Cytodyn Inc

RCKT

Rocket Pharmaceuticals Inc

Compare $CYDY vs $RCKT

Comparing Cytodyn Inc and Rocket Pharmaceuticals Inc

CYDYCytodyn Inc

RCKTRocket Pharmaceuticals Inc

CYDYCytodyn Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.2%

FCF yield

-6.3%

RCKTRocket Pharmaceuticals Inc

Market cap

$280M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.18x

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.5%

FCF yield

-61.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYDY

RCKT

Detailed metrics comparison

CYDY

Cytodyn Inc

RCKT

Rocket Pharmaceuticals Inc

Market Cap

CYDY$274M

RCKT$280M

Enterprise Value

CYDY$289M

RCKT$76M

Price

CYDY$0.20

RCKT$2.56

P/E Ratio

CYDYN/A

RCKTN/A

P/S Ratio

CYDY0.00x

RCKT0.00x

EV/Sales

CYDY0.00x

RCKT0.00x

EV/EBITDA

CYDY34.72x

RCKT8.60x

P/B Ratio

CYDY106.18x

RCKT0.76x

P/FCF Ratio

CYDYN/A

RCKTN/A

EV/FCF

CYDY-16.77x

RCKT-0.45x

PEG Ratio

CYDYN/A

RCKTN/A

Forward P/E (NTM)

CYDYN/A

RCKTN/A

Forward P/S (NTM)

CYDYN/A

RCKT34.18x

Revenue (TTM)

CYDY$0

RCKT$0

Revenue Growth (YoY)

CYDYN/A

RCKTN/A

Forward Rev Growth

CYDY0.0%

RCKT833.4%

Gross Margin (TTM)

CYDY0.0%

RCKT0.0%

Operating Margin (TTM)

CYDY0.0%

RCKT0.0%

EBITDA Margin (TTM)

CYDY0.0%

RCKT0.0%

Net Margin (TTM)

CYDY0.0%

RCKT0.0%

FCF Margin (TTM)

CYDYN/A

RCKTN/A

Net Income (TTM)

CYDY$-44M

RCKT$-17M

FCF (TTM)

CYDY$-17M

RCKT$-171M

EPS (TTM)

CYDY-$0.03

RCKT-$0.15

ROE (TTM)

CYDY-111387.0%

RCKT-576.0%

ROA (TTM)

CYDY-31117.0%

RCKT-490.0%

ROIC (TTM)

CYDY-8873.0%

RCKT-538.0%

Cash

CYDY$12M

RCKT$225M

Debt

CYDY$27M

RCKT$21M

Net Cash/Debt

CYDY$-15M

RCKT$203M

Current Ratio (TTM)

CYDY0.26x

RCKT9.24x

Quick Ratio (TTM)

CYDY0.22x

RCKT9.06x

Debt/Equity (TTM)

CYDY11.55x

RCKT0.06x

Debt/Assets (TTM)

CYDY0.0%

RCKT0.0%

Interest Coverage (TTM)

CYDYN/A

RCKTN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

RCKT0.00x

Beta

CYDY1.76

RCKT0.48

52W Performance

CYDY-24.2%

RCKT-24.5%

YTD Performance

CYDY-26.0%

RCKT-26.0%

% from 52W High

CYDY-49.6%

RCKT-53.0%

% from 52W Low

CYDY9.3%

RCKT5.8%

Asset Turnover (TTM)

CYDY0.00x

RCKT0.00x

FCF Yield (TTM)

CYDY-6.3%

RCKT-61.0%

Earnings Yield (TTM)

CYDY-16.1%

RCKT-6.2%

Dividend Yield (TTM)

CYDYN/A

RCKTN/A

Rule of 40

CYDY0.0

RCKT0.0

EV/GP/RG

CYDYN/A

RCKTN/A

Ticker research

View CYDY research View RCKT research

Metric	CYDY Cytodyn Inc	RCKT Rocket Pharmaceuticals Inc
Market & Valuation
Market Cap	$274M	$280M
Enterprise Value	$289M	$76M
Price	$0.20	$2.56
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	34.72x	8.60x
P/B Ratio	106.18x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	34.18x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	833.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-17M
FCF (TTM)	$-17M	$-171M
EPS (TTM)	-$0.03	-$0.15
ROE (TTM)	-111387.0%	-576.0%
ROA (TTM)	-31117.0%	-490.0%
ROIC (TTM)	-8873.0%	-538.0%
Financial Health
Cash	$12M	$225M
Debt	$27M	$21M
Net Cash/Debt	$-15M	$203M
Current Ratio (TTM)	0.26x	9.24x
Quick Ratio (TTM)	0.22x	9.06x
Debt/Equity (TTM)	11.55x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.48
52W Performance	-24.2%	-24.5%
YTD Performance	-26.0%	-26.0%
% from 52W High	-49.6%	-53.0%
% from 52W Low	9.3%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.3%	-61.0%
Earnings Yield (TTM)	-16.1%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View RCKT research

Valuation

P/S Ratio

CYDY

0.00x

RCKT

0.00x

EV/FCF

CYDY

-16.77x

RCKT

-0.45x

Growth & revenue

Forward Revenue Growth

RCKT

833.4%

CYDY

0.0%

Profitability & performance

Gross Margin

CYDY

0.0%

RCKT

0.0%

ROE

RCKT

-576.0%

CYDY

-111387.0%

FCF Yield %

CYDY

-6.3%

RCKT

-61.0%

52-Week Performance

CYDY

-24.2%

RCKT

-24.5%

Detailed metrics comparison

CYDY

Cytodyn Inc

RCKT

Rocket Pharmaceuticals Inc

Market Cap

CYDY$274M

RCKT$280M

Enterprise Value

CYDY$289M

RCKT$76M

Price

CYDY$0.20

RCKT$2.56

P/E Ratio

CYDYN/A

RCKTN/A

P/S Ratio

CYDY0.00x

RCKT0.00x

EV/Sales

CYDY0.00x

RCKT0.00x

EV/EBITDA

CYDY34.72x

RCKT8.60x

P/B Ratio

CYDY106.18x

RCKT0.76x

P/FCF Ratio

CYDYN/A

RCKTN/A

EV/FCF

CYDY-16.77x

RCKT-0.45x

PEG Ratio

CYDYN/A

RCKTN/A

Forward P/E (NTM)

CYDYN/A

RCKTN/A

Forward P/S (NTM)

CYDYN/A

RCKT34.18x

Revenue (TTM)

CYDY$0

RCKT$0

Revenue Growth (YoY)

CYDYN/A

RCKTN/A

Forward Rev Growth

CYDY0.0%

RCKT833.4%

Gross Margin (TTM)

CYDY0.0%

RCKT0.0%

Operating Margin (TTM)

CYDY0.0%

RCKT0.0%

EBITDA Margin (TTM)

CYDY0.0%

RCKT0.0%

Net Margin (TTM)

CYDY0.0%

RCKT0.0%

FCF Margin (TTM)

CYDYN/A

RCKTN/A

Net Income (TTM)

CYDY$-44M

RCKT$-17M

FCF (TTM)

CYDY$-17M

RCKT$-171M

EPS (TTM)

CYDY-$0.03

RCKT-$0.15

ROE (TTM)

CYDY-111387.0%

RCKT-576.0%

ROA (TTM)

CYDY-31117.0%

RCKT-490.0%

ROIC (TTM)

CYDY-8873.0%

RCKT-538.0%

Cash

CYDY$12M

RCKT$225M

Debt

CYDY$27M

RCKT$21M

Net Cash/Debt

CYDY$-15M

RCKT$203M

Current Ratio (TTM)

CYDY0.26x

RCKT9.24x

Quick Ratio (TTM)

CYDY0.22x

RCKT9.06x

Debt/Equity (TTM)

CYDY11.55x

RCKT0.06x

Debt/Assets (TTM)

CYDY0.0%

RCKT0.0%

Interest Coverage (TTM)

CYDYN/A

RCKTN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

RCKT0.00x

Beta

CYDY1.76

RCKT0.48

52W Performance

CYDY-24.2%

RCKT-24.5%

YTD Performance

CYDY-26.0%

RCKT-26.0%

% from 52W High

CYDY-49.6%

RCKT-53.0%

% from 52W Low

CYDY9.3%

RCKT5.8%

Asset Turnover (TTM)

CYDY0.00x

RCKT0.00x

FCF Yield (TTM)

CYDY-6.3%

RCKT-61.0%

Earnings Yield (TTM)

CYDY-16.1%

RCKT-6.2%

Dividend Yield (TTM)

CYDYN/A

RCKTN/A

Rule of 40

CYDY0.0

RCKT0.0

EV/GP/RG

CYDYN/A

RCKTN/A

Ticker research

View CYDY research View RCKT research

Metric	CYDY Cytodyn Inc	RCKT Rocket Pharmaceuticals Inc
Market & Valuation
Market Cap	$274M	$280M
Enterprise Value	$289M	$76M
Price	$0.20	$2.56
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	34.72x	8.60x
P/B Ratio	106.18x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	34.18x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	833.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-17M
FCF (TTM)	$-17M	$-171M
EPS (TTM)	-$0.03	-$0.15
ROE (TTM)	-111387.0%	-576.0%
ROA (TTM)	-31117.0%	-490.0%
ROIC (TTM)	-8873.0%	-538.0%
Financial Health
Cash	$12M	$225M
Debt	$27M	$21M
Net Cash/Debt	$-15M	$203M
Current Ratio (TTM)	0.26x	9.24x
Quick Ratio (TTM)	0.22x	9.06x
Debt/Equity (TTM)	11.55x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.48
52W Performance	-24.2%	-24.5%
YTD Performance	-26.0%	-26.0%
% from 52W High	-49.6%	-53.0%
% from 52W Low	9.3%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.3%	-61.0%
Earnings Yield (TTM)	-16.1%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View RCKT research